Navigation Links
Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
Date:11/24/2009

IRVINE, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has filed a motion to stay, or discontinue all proceedings in, the patent infringement lawsuit brought against it in October 2009 by Cook, Inc. The motion was filed in the United States District Court in Indianapolis, Indiana.

Endologix has requested that the stay remain in effect while the United States Patent and Trademark Office (USPTO) conducts proceedings to re-examine the two patents asserted by Cook in the lawsuit and determine whether it should have granted Cook the patents. Endologix has already filed papers requesting that the USPTO re-examine the two Cook patents, based on patents that pre-date Cook's patents and were not previously considered by the USPTO in its decision to grant the patents to Cook.

John McDermott, Endologix President and Chief Executive Officer, said, "In addition to contesting the validity of Cook's patents, we also intend to challenge the lawsuit on other grounds, including non-infringement of the Cook patents by our products. We continue to believe we have support for numerous promising defenses against this infringement case."

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Additional information can be found on Endologix's Web site at '/>"/>

Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
6. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
7. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
8. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
9. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
10. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
11. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Calif. , May 21, 2013 RenovoRx ... prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, ... innovation, strong management team and quality of entrepreneurial ideas. ... at the Santa Clara Convention ... highly influential list of the most enterprising startup companies ...
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay .  "No ... to attend this year.  The show,s still 4 months ... companies.  This is a big surprise and great ...
Breaking Medicine Technology:RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2
... Conn., Jan. 7 Alexion,Pharmaceuticals, Inc. (the ... commenced dosing in the AEGIS study, a ... and pharmacology of Soliris(R) (eculizumab),as a treatment ... When fully enrolled, the open-label study, authorized,by ...
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... phase 2 clinical trials sponsored by its ... CollaRx(R) BUPIVACAINE SURGICAL,IMPLANT for the management of ... BUPIVACAINE SURGICAL IMPLANT is a biodegradable and ...
Cached Medicine Technology:Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 2Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 3Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 4Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 5Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 6Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4
(Date:5/21/2013)... on a large scale is the cornerstone of ... better outcomes, better value and better experience of ... patient-centered medical home model offers a viable solution ... of Health and Human Services, Agency for Healthcare ... more about the processes and determinants of successful ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 HealthSmart continues ... expanding national presence has required the hiring of new ... HealthSmart is pleased to announce that Dawn Powell has ... serving as the Director of Account Management in the ... offices in Irving, Texas. With extensive client management, employee ...
(Date:5/21/2013)... According to a May 13, 2013 New Zealand ... Botox injections have become the most popular cosmetic ... to goo.gl/8iYbD). Although it is mostly associated with women, ... makes facial wrinkles less visible by paralyzing facial muscles. The ... months. This means that people who are conscious about their ...
(Date:5/21/2013)... Los Angeles, CA (PRWEB) May 21, 2013 ... combat sports organization, and Bodybuilding.com, the largest online retailer ... bring you a new reality-based sports show, Warrior Island. ... fans vote on; YouTube, Facebook & Twitter, with our ... Warrior Island maroons these elite fighters on an ...
(Date:5/21/2013)... Research into genetic features of pulmonary fibrosis by physicians ... Medicine may lead to improved treatment of this deadly ... JAMA . , The study found that a ... of pulmonary fibrosis, a chronic progressive disease with a ... the study, researchers may want to consider including genetic ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2
... TORONTOA large group of soldiers returning from Iraq ... the small airways of the lung, according to ... their findings at the American Thoracic Societys 2008 ... A total of 56 soldiers from Fort Campbell, ...
... 21 The warm weather provides the,perfect opportunity ... and confidence,with a plan that combines smarter eating ... http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ), "The key to controlling ... activity," said Peggy Fleming, Olympic figure skating,champion and ...
... Program Provides Continuing CKD Nutrition Education for Non-Renal ... ... a leading,provider of kidney care services for those diagnosed with chronic ... (Expand Your Expertise in CKD Nutrition) workshop on March 6,2008 in ...
... SHANGHAI, China, May 21 /Xinhua-PRNewswire/ -- WuXi ... medical device research,and development outsourcing company with ... proud to announce that the distinguished Stanford ... ) has,visited WuXi PharmaTech and given ...
... N.Y., May 21 Babies born,preterm were more than ... infants, according to a new analysis of nearly 7 ... Springer journal Maternal and,Child Health Journal., Preterm birth, ... national health crisis, according to the March of Dimes. ...
... WASHINGTON, May 20 Accelerate Brain Cancer,Cure ... its,website from leading brain cancer specialists covering important ... as valuable guidance for newly,diagnosed brain cancer patients., ... with some of the worlds,leading researchers in the ...
Cached Medicine News:Health News:Iraq war service: A risk factor for bronchiolitis? 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 5Health News:DaVita Renal Dietitians Conduct First-Ever 'EYE on CKD' Workshop 2Health News:Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars 2Health News:Analysis of Millions of U.S. Births Shows Association Between Birth Defects and Preterm Birth 2Health News:Brain Cancer Science and Treatment Information 2
The TBR-360-1-GD is a large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standar...
... is specially designed for ... in standard 500ml bags, ... AS3864 1997. Quiet hermetic ... CFC Free refrigerant with ...
... a direct competitive EIA for the ... serum or plasma. A specific agent ... it available for antibody binding. Testosterone ... linked to fluorescein isothiocyanate (FITC) and ...
... Vitamin B6 makes it possible to determine ... precise method. The kits includes all reagents ... separation of the samples with,exception of the ... the simultaneous handling of many analytes in ...
Medicine Products: